Frederick G Moeller
Virginia Commonwealth University · UTHSC-Houston · The University of Texas Health Science Center, Houston
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
14
all conditions, ClinicalTrials.gov
NIH grants tied to them
19
1 more share only the name and are not shown
Trial papers
40
PubMed author-name match
Trials
Studies that name Frederick G Moeller as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:51 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05976646 · Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg BupropionVirginia Commonwealth University · completed · Addiction, Opioid Use, Substance Use Disorders · principal investigator
- Ph1/Ph2NCT04818086 · Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use DisorderVirginia Commonwealth University · completed · Drug Interaction, Analgesics, Opioid Use Disorder · principal investigator
- Ph3NCT04523792 · Virginia Opioid Treatment-Emergency DepartmentVirginia Commonwealth University · withdrawn · Opioid Use Disorder · principal investigator
- Ph3NCT03818399 · Virginia Opioid Overdose Treatment InitiatVEVirginia Commonwealth University · terminated · Opioid Use Disorder · principal investigator
- Early Ph1NCT03489161 · Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid WithdrawalVirginia Commonwealth University · completed · Drug Overdose, Opioid Withdrawal, Opioid-use Disorder · principal investigator
- Ph1NCT03143855 · Drug Interaction and Subjective Effects of Compounds for Opioid Use DisorderVirginia Commonwealth University · completed · Opioid Abuse, Opioid Dependence, Opioid-Related Disorders · principal investigator
- Ph1NCT02537873 · Drug Interaction and Self Administration Studies of Compounds for Cocaine Use DisorderVirginia Commonwealth University · completed · Cocaine Use Disorder · principal investigator
- Ph2NCT02080832 · Brain Function and Structure in Cocaine DependenceVirginia Commonwealth University · completed · Cocaine Dependence · principal investigator
- Early Ph1NCT00783276 · An fMRI Study of SYN115 in Cocaine Dependent SubjectsVirginia Commonwealth University · completed · Cocaine Dependence · principal investigator
- Ph1/Ph2NCT00733993 · Caffeine and CocaineVirginia Commonwealth University · completed · Cocaine Dependence · principal investigator
- Ph2/Ph3NCT00732901 · Clinical Neurobiology of Serotonin and AddictionVirginia Commonwealth University · completed · Cocaine Dependence · principal investigator
- N/ANCT00439049 · Substance Abuse Pre-Treatment Screening StudyThe University of Texas Health Science Center, Houston · unknown · Cocaine Abuse, Cocaine Dependence, Opiate Dependence · principal investigator
- Ph2NCT00297505 · Serotonin, Impulsivity, and Cocaine Dependence TreatmentNational Institute on Drug Abuse (NIDA) · completed · Cocaine Dependence · principal investigator
- N/ANCT00217997 · Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent IndividualsThe University of Texas Health Science Center, Houston · completed · Cocaine Abuse, Cocaine-Related Disorders · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD) - Virginia Commonwealth UniversityU01AA026979 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · fiscal years 2024 to 2026 · $341,550 awarded in 2026Same name and institution; not confirmed by an ID
- Novel 5-HT2A/mGluR5 Antagonist for Opioid Use DisorderUG3DA063353 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · fiscal years 2025 to 2026 · $1,136,467 awarded in 2026Same name and institution; not confirmed by an ID
- Wright Regional Center for Clinical and Translational ScienceUM1TR004360 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · fiscal years 2023 to 2026 · $3,931,548 awarded in 2026Same name and institution; not confirmed by an ID
- Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use DisordersUG1DA050207 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · fiscal years 2020 to 2024 · $504,103 awarded in 2024Grant number is on one of their registry trials
- Center for Clinical and Translational ResearchUL1TR002649 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · fiscal years 2018 to 2022 · $3,703,862 awarded in 2022Same name and institution; not confirmed by an ID
- NOP Receptor Antagonist for OUD PharmacotherapyUG3DA052282 · NIDA · UNIVERSITY OF TEXAS MED BR GALVESTON · fiscal years 2020 · $2,793,808 awarded in 2020Same name and institution; not confirmed by an ID
- Novel LAAM formulations to treat Opioid Use Disorder (UG3 DA048768-01A1)UG3DA048768 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · fiscal years 2019 · $1,614,668 awarded in 2019Same name and institution; not confirmed by an ID
- Preclinical Assessment of Compounds for Cocaine Use Disorder (CocUD)U54DA038999 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · fiscal years 2014 to 2018 · $291,156 awarded in 2018Grant number is on one of their registry trials
- Serotonergic Regulation of Corticostriatal Connectivity in Cocaine DependenceP50DA033935 · NIDA · UNIVERSITY OF TEXAS MED BR GALVESTON · fiscal years 2013 to 2017 · $273,287 awarded in 2017Same name and institution; not confirmed by an ID
- Center for Clinical and Translational ResearchUL1TR000058 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · fiscal years 2014 to 2015 · $2,158,928 awarded in 2015Same name and institution; not confirmed by an ID
- Administrative CoreP50DA009262 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · fiscal years 2005 to 2014 · $772,183 awarded in 2014Grant number is on one of their registry trials
- Center for Clinical and Translational ResearchKL2TR000057 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · fiscal years 2014 · $427,924 awarded in 2014Same name and institution; not confirmed by an ID
- CLINICAL NEUROBIOLOGY OF SEROTONIN AND ADDICTIONP20DA024157 · NIDA · UNIVERSITY OF TEXAS MED BR GALVESTON · fiscal years 2007 to 2012 · $229,529 awarded in 2012Grant number is on one of their registry trials
- Serotonin, Impulsivity, and Substance AbuseK02DA000403 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · fiscal years 2000 to 2011 · $117,612 awarded in 2011Same name and institution; not confirmed by an ID
- Scientific Meeting of ISRIR13DA020339 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · fiscal years 2005 · $25,000 awarded in 2005Same name and institution; not confirmed by an ID
- SEROTONIN AND AGGRESSION IN COCAINE DEPENDENCEM01RR002558 · NCRR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · fiscal years 1998 to 2005 · $4,865 awarded in 2005Same name and institution; not confirmed by an ID
- Serotonin, Drug Use and MDMA Induced DeficitsR01DA015345 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · fiscal years 2003 to 2005 · $371,250 awarded in 2005Same name and institution; not confirmed by an ID
- SEROTONIN, IMPULSIVITY AND COCAINE DEPENDENCE TREATMENTR01DA008425 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · fiscal years 1996 to 2004 · $249,430 awarded in 2004Same name and institution; not confirmed by an ID
- ANTISOCIAL PERSONALITY AND ALCOHOL INDUCED AGGRESSIONR01AA010828 · NIAAA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · fiscal years 1997 to 1999 · $141,147 awarded in 1999Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:51 UTC. The ranking covers the 200 most relevant of 40 PubMed records, and a shared surname and initials can bring in a namesake. All 40 on PubMed
- The impact of impulsivity on cocaine use and retention in treatment.J Subst Abuse Treat · 2001312 citationsRCR 9.7
- Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial.J Clin Psychopharmacol · 2001202 citationsRCR 5.9
- Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.Neuropsychopharmacology · 2004153 citationsRCR 4.7
- Laboratory measures of aggression and impulsivity in women with borderline personality disorder.Psychiatry Res · 1999146 citationsRCR 5.4
- Tryptophan depletion and aggressive responding in healthy males.Psychopharmacology (Berl) · 199694 citationsRCR 3.5
- Fluoxetine treatment of cocaine-dependent patients with major depressive disorder.Drug Alcohol Depend · 200191 citationsRCR 3.1
- Effects of moderate and high doses of alcohol on attention, impulsivity, discriminability, and response bias in immediate and delayed memory task performance.Alcohol Clin Exp Res · 200080 citationsRCR 3.1
- Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial.Am J Drug Alcohol Abuse · 200778 citationsRCR 2.5
- Working memory fMRI activation in cocaine-dependent subjects: association with treatment response.Psychiatry Res · 201077 citationsRCR 2.5
- P300 event-related potential amplitude and impulsivity in cocaine-dependent subjects.Neuropsychobiology · 200473 citationsRCR 2.3